XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.25.3

STOCK OPTIONS AND WARRANTS (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract] |
SCHEDULE OF STOCK OPTIONS | The following table summarizes all stock options as of September 30, 2025 (shares in thousands): SCHEDULE OF STOCK OPTIONS
|  | 2025 |
|  | Shares |  |  | Price (1) |  |  | Term (2) |
Outstanding, at December 31, 2024 |  |  | 1,238 |  |  | $ | 8.80 |  |  |  | 8.5 |
Granted |  |  | - |  |  |  | - |  |  |  |  |
Forfeited |  |  | (13 | ) |  |  | - |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Outstanding, at September 30 |  |  | 1,225 | (3) |  | $ | 7.04 |  |  |  | 7.8 |
Exercisable, at September 30 |  |  | 163 | (4) |  |  | 29.28 |  |  |  | 2.5 |
(1) | Represents the weighted average exercise price.
(2) | Represents the weighted average remaining contractual term until the stock options expire.
(3) | As of September 30, 2025, the aggregate intrinsic value of stock options outstanding was $0.
(4) | As of September 30, 2025, the aggregate intrinsic value of exercisable stock options was $0.
SCHEDULE OF WARRANT OUTSTANDING | The following table sets forth activity with respect to the Company’s warrants to purchase Common Stock for the nine months ended September 30, 2025 (shares in thousands): SCHEDULE OF WARRANT OUTSTANDING
|  | 2025 |
|  | Shares |  |  | Price (1) |  |  | Term (2) |
Outstanding, at December 31, 2024 |  |  | 9,658 |  |  | $ | 3.22 |  |  |  | 3.9 |
Grants of warrants: |  |  |  |  |  |  |  |  |  |  |  |
Private placement |  |  | 3,055 |  |  |  |  |  |  |  |  |
Warrant inducement |  |  | - |  |  |  |  |  |  |  |  |
Exercised |  |  | (180 | ) |  |  |  |  |  |  |  |
Forfeited |  |  | (735 | ) |  |  |  |  |  |  |  |
Outstanding, at June 30 |  |  | 11,798 | (3) |  | $ | 2.69 |  |  |  | 3.6 |
Exercisable, at June 30 |  |  | 11,745 | (4) |  | $ | 2.60 |  |  |  | 3.5 |
(1) | Represents the weighted average exercise price.
(2) | Represents the weighted average remaining contractual term until the warrants expire.
(3) | As of September 30, 2025, the aggregate intrinsic value of warrants outstanding was $0 million.
(4) | As of September 30, 2025, the aggregate intrinsic value of warrants exercisable was $0 million.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the change in stock options. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration